The Latest: Italy surpasses 3 million coronavirus cases

Friday, March 5, 2021 | The Associated Press

Signs reading in Italian "No gathering" hang from a closed gate of the Cesare Battisti primary school, in Rome, Thursday, March 4, 2021. The first anti-pandemic decree from Italy's new premier, Mario Draghi, tightens measures governing school attendance while easing restrictions on museums, theaters and cinemas. (AP Photo/Gregorio Borgia)

ROME — Italy surpassed 3 million confirmed coronavirus cases on Friday, the third straight day this week that daily new caseloads exceeded 20,000 cases.

With the 24,036 new confirmed infections registered by the Health Ministry, Italy has reached 3,023,129 cases. The actual total is widely considered higher because testing wasn’t extensive early in the pandemic.

The virus variant first found in England is potentially fueling the increase, along with another variant, detected in Brazil. Italy registered 297 more deaths, raising the confirmed death toll to 99,271.

“We can’t wait for more vaccines and doses of vaccines to arrive,’’ said Dr. Gianni Rezza, a health ministry official, noting the slow delivery of shots.

In Italy, some 3.5 million people have received at least one dose of a COVID-19 vaccine.



— New York Gov. Andrew Cuomo’s health department confirmed reports of altered nursing home deaths

— AP-NORC poll: Americans largely back Biden’s virus response

— Canada OKs Johnson & Johnson shot, getting 4th vaccine for nation

— Pope urges Iraq to embrace its Christians on historic visit

— Follow AP’s pandemic coverage at, and



GENEVA — The head of the World Health Organization called for patent rights to be waived until the end of the coronavirus pandemic so vaccine supplies can be dramatically increased.

WHO chief Tedros Adhanom Ghebreyesus says countries with their own vaccine capacity should “start waiving intellectual property rights” as provided in special emergency provisions from the World Trade Organization.

“These provisions are there for use in emergencies,” Tedros said. “If now is not a time to use them, then when?” He said WHO would be meeting soon with representatives and the industry to identify bottlenecks in production and discuss how to solve them.

Tedros commended AstraZeneca for sharing its COVID-19 vaccine technology with companies, including the Serum Institute of India.

Tedros noted although the U.N. backed effort known as COVAX has delivered vaccines to more than 20 countries this week, the amounts are only enough to protect about 2 to 3% of each country’s population.


NEW YORK — Gov. Andrew Cuomo’s health department confirmed reports late Thursday that members of his COVID-19 task force altered a New York state Health Department report to omit the full number of nursing home patients killed by the coronavirus, but insisted the changes were made because of concerns about the data’s accuracy.

The Wall Street Journal and The New York Times, citing documents and people with knowledge of the administration’s internal discussions, reported that aides including secretary to the governor Melissa DeRosa pushed state health officials to edit the July report so it counted only residents who died inside long-term care facilities, and not those who became ill there and later died at a hospital.

The state now acknowledges that at least 15,000 long-term care residents died, compared to a figure of 8,700 it had publicized as of late January that didn’t include residents who died after being transferred to hospitals.


WASHINGTON — The White House says two new mass vaccination sites will soon be open, in Atlanta and Cleveland, each with the ability to provide 6,000 daily coronavirus shots.

Coronavirus special adviser Andy Slavitt says the FEMA-supported centers will operate from Mercedes-Benz stadium in Atlanta, which is home to the NFL’s Falcons, and the Wolstein Center in Cleveland.

Slavitt says it brings the total of FEMA-supported sites to 18, with the capacity to provide 60,000 daily shots. There are 450 community vaccination centers already in operation.

More than 54 million Americans have received at least one shot. Nearly 28 million people, representing about 8% of the population, have completed their vaccinations.


INDIANANPOLIS — Indiana Gov. Eric Holcomb received his COVID-19 vaccine shot Friday at the Indianapolis Motor Speedway for the opening of the state’s first mass vaccination clinic.

Holcomb wore a face mask in the front passenger seat of an SUV while getting the shot of the single-dose Johnson & Johnson vaccine at the drive-through clinic.

Holcomb says his message is: “This is going to help us beat COVID-19. The more, the faster.”

The state health department says nearly 17,000 people had filled up four days of appointments for the speedway clinic held Friday through Monday. About 630,000 people, or nearly 10% of Indiana’s population, were fully vaccinated through Wednesday.


TORONTO — Canada is getting a fourth vaccine to prevent COVID-19, approving the Johnson & Johnson shot that works with just one dose.

Health experts are eager for a one-and-done option to help speed vaccination. Canada has also approved vaccines from Pfizer, Moderna and AstraZeneca. Health Canada is the first major regulator to approve four difference vaccines.

Canada doesn’t have domestic production and has struggled with a shortage of vaccines. The U.S. isn’t exporting locally made vaccines, so neighbors Canada and Mexico must get vaccines from Europe and Asia.

Canada has pre-purchased 10 million Johnson & Johnson doses, with options to buy another 28 million.

The U.S. approved the Johnson & Johnson vaccine last month. The U.S. Food and Drug Administration says one dose was 85% protective against the most severe COVID-19 illness in a massive study that spanned three continents.


BERLIN — The head of Germany’s disease control agency is urging people to get vaccinated for the coronavirus when given the opportunity, no matter which vaccine is offered.

The comments Friday from Robert Koch Institute President Lothar Wieler come amid reports some have declined the AstraZeneca shot.

Germany’s independent vaccine committee on Thursday approved AstraZeneca for people 65 and over. Several countries, including Germany, initially restricted it to people under 65, or in some cases under 55, citing a lack of data on its effectiveness in older people.

Germany is also administering the Pfizer and Moderna vaccines.

“If you are offered a vaccine, please get yourself vaccinated. They are safe and effective,” Wieler says, adding that vaccinating large numbers of people is “the way out of the pandemic.”


WARSAW, Poland — Poland’s government plans to open temporary hospitals and impose partial localized lockdowns.

Health Minister Adam Niedzielski says the government will open more temporary hospitals on Wednesday because of a rise in infections. Niedzielski says it’s partly because of the British variant.

With nearly 16,000 new cases recorded Friday, Niedzielski says that level could rise to 18,000 new daily cases or more next week.


ISLAMABAD — A Pakistani official says authorities are hoping to start receiving the AstraZeneca vaccine in the middle of this month under the WHO’s COVAX Facility.

Sajjad Hussain Shah, a spokesman at ministry of health services, says Pakistan will receive 17 million doses coronavirus vaccines under the COVAX program from March to June. It will be in addition to 500,000 doses of Chinese Sinopharm vaccine which Pakistan will get from Beijing next week.

China had promised to donate 1 million doses of vaccine to Pakistan. Last month, Pakistan received 500,000 doses.

Pakistan is currently using Chinese vaccines for health workers and elderly people amid a steady increase in deaths and cases from COVID-19. Pakistan allocated $250 million to buy vaccines, and authorities say they were still in talks with manufacturers of vaccines.

Also, Pakistan had allowed its private sector to import vaccines, but so far no private laboratory has started vaccinations for unexplained reasons.

Pakistan has reported 13,128 confirmed deaths among 587,014 confirmed cases since the start of the pandemic.


WASHINGTON — President Joe Biden has a 60% approval rating of his job performance from Americans and even more backing for his handling of the coronavirus pandemic.

That’s according to a new poll from The Associated Press-NORC Center for Public Affairs Research. Support for Biden’s pandemic response extends across party lines. Overall, 70% of Americans back his handling of the virus response, including 44% of Republicans.

Biden has made the pandemic his central focus, urging Americans to follow stringent social distancing and mask guidelines and vowing to speed up distribution of critical vaccines. He’s also argued that until the spread of the virus is under control, the economy won’t fully recover.

Overall, 48% of Americans say the country is headed in the right direction, compared with 37% in December.


BAGHDAD — Pope Francis has arrived in Iraq to urge the country’s dwindling number of Christians to stay put and help rebuild the country after years of war and persecution, brushing aside the coronavirus pandemic and security concerns.

Iraqis men were seen welcoming him along roadsides, most without masks. Iraq’s foreign minister described the visit as a historic meeting between the “minaret and the bells,” saying Iraqis were eager to welcome Francis’ “message of peace and tolerance.”

The pope, who wore a facemask during the flight, kept it on as he descended the stairs to the tarmac and was greeted by two masked children in traditional dress. But health measures appeared lax inside the airport despite the country’s worsening coronavirus outbreak.

The 84-year-old pope, the Vatican delegation and travelling media have been vaccinated; most Iraqis have not. Iraqi security forces are on hand to protect the delegation, along with the expected first use of an armored car for the popemobile-loving pontiff.


SAN DIEGO — The San Diego Zoo has vaccinated nine great apes for the coronavirus after a troop of gorillas in its Safari Park became infected.

Officials say four orangutans and five bonobos received COVID-19 injections in January and February.

Three bonobos and a gorilla also are expected to receive the vaccine, which is experimental.

The vaccinations followed a January outbreak of COVID-19 at the zoo’s Safari Park. Eight western lowland gorillas got the virus, probably by exposure to a zookeeper who tested positive for COVID-19.

The gorillas had symptoms ranging from runny noses to coughing and lethargy. But they are recovering.


WELLINGTON, New Zealand — New Zealand’s largest city will exit a weeklong lockdown on Sunday morning after the latest coronavirus outbreak appears to have been stamped out.

There have been no new community cases of the virus found in Auckland or elsewhere in New Zealand for the past five days.

Prime Minister Jacinda Ardern said on Friday that Auckland would move to Alert Level 2 from 6 a.m. Sunday while the rest of New Zealand would move to Alert Level 1. Level 2 places limits on crowd sizes but allows people to continue most aspects of life as normal, while Level 1 requires only that people wear masks on public transport.

Auckland had gone six months without a lockdown before 15 community cases of the more transmissible variant first found in Britain were discovered in February, prompting an initial three-day lockdown followed later by the weeklong lockdown.

Ardern made the decision to ease restrictions after meeting with senior lawmakers in the Cabinet.


SALT LAKE CITY — Utah will open up COVID-19 vaccine appointments to people ages 50 and older on Monday.

Republican Gov. Spencer Cox made the announcement during his weekly pandemic briefing Thursday.

Cox also said that Utah residents 18 and older with certain health conditions — diabetes, chronic kidney disease or obesity — can start making vaccine appointments next week.

The expansion will mean 700,000 more state residents can be vaccinated. People with a body mass index of 30 or higher can also be vaccinated. The previous threshold was 40 or higher.

Cox also announced last week that Utah had been approved to get 20,000 doses of the new single-dose Johnson & Johnson vaccine.


Featured Article: What is Depreciation?

7 Marijuana Stocks Worth Speculating On

To say it’s been a rough two years for the cannabis industry is an understatement. Due to a combination of issues (including some self-inflicted wounds), the cannabis boom predicted in 2018 has not materialized. But that could be about to change.

If Joe Biden wins the presidential election, it will likely be part of a “Blue Wave” that will bring Democratic party control of both houses of Congress. And even if President Trump successfully wins a second term, it is still possible that Republicans could lose their hold on the Senate.

The bottom line is there is a range of outcomes that are possible. Most of those outcomes are favorable to the legalization of marijuana. And even if cannabis is not made legal on the federal level, it seems likely that the remaining states holding out will take steps to legalization. That’s because, like gambling, cannabis may create an economic lift that cash-strapped states may find too difficult to turn down.

One thing is certain. If you wait until the right time, you’ll have missed out on some eye-popping initial gains. But to get that reward in the future, you’ll need to assume some risk now. In this special presentation, we’ve identified seven cannabis stocks that you can consider when evaluating your opportunity in the cannabis sector.

View the "7 Marijuana Stocks Worth Speculating On ".

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)2.7$161.42+0.9%2.50%25.38Buy$180.64
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.